Briacell Therapeutics Corp. BCTX Q3 2025 Annual earnings
Reported October 27, 2025 · Before market open
EPS-$10.49Beat by $1.62
EPS estimate-$12.11
Next report
Date not yet announcedVersus estimates
Diluted EPS
Q2 2026-$0.99Q1 2026-$2.58Beat by $2.26Q4 2025-$4.35
Q3 2025-$10.49Beat by $1.62
Q2 2025-$16.40Beat by $1.20Q1 2025-$23.30Miss by $3.90Ask the moment Briacell Therapeutics Corp. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Briacell Therapeutics Corp. report Q3 2025 earnings?
- Briacell Therapeutics Corp. (BCTX) reported Q3 2025 earnings on October 27, 2025 before market open.
- What were Briacell Therapeutics Corp.'s Q3 2025 revenue and EPS?
- Briacell Therapeutics Corp. reported eps of $-10.49 for Q3 2025.
- Did Briacell Therapeutics Corp. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-12.11 by $1.62.
- How did Briacell Therapeutics Corp.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 1340.9% from $-0.73.
- Where can I find Briacell Therapeutics Corp.'s Q3 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-25-018212) directly on SEC EDGAR. The filing index links above go to sec.gov.